750 Preclinical characteristics of ITMN-B, an orally active inhibitor of the HCV NS3/4A protease nominated for preclinical development

Authors:
  • SSS.D. Seiwert
    S.D. Seiwert
  • SAS.W. Andrews
    S.W. Andrews
  • HTH. Tan
    H. Tan
  • TWT. Wang
    T. Wang
  • BMB. Marafino
    B. Marafino
  • RRR. Rieger
    R. Rieger
  • JPJ. Pheneger
    J. Pheneger
  • PLP.A. Lee
    P.A. Lee
  • YJY. Jiang
    Y. Jiang
  • AKA.L. Kennedy
    A.L. Kennedy
  • JBJ. Ballard
    J. Ballard
  • HZH. Zhang
    H. Zhang
Publisher website
Google Scholar
Abstract
No abstract available